GC
IMNN icon

Guggenheim Capital’s Imunon IMNN Stock Holding History

Guggenheim Capital’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6
Closed -$5K – 2885
2016
Q4 		$5K Hold
6
– – ﹤0.01% 2894
2016
Q3 		$19K Buy
+6
New +$20.5K ﹤0.01% 2827
2013
Q4 		– Sell
-2
Closed -$23K – 3219
2013
Q3 		$23K Buy
2
+1
+100% +$14.8K ﹤0.01% 3007
2013
Q2 		$13K Buy
+1
New +$13.9K ﹤0.01% 3007

Other funds holding IMNN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guggenheim Capital's IMNN Position: Q1 2017 in Review

Guggenheim Capital sold out of Imunon (IMNN) in Q1 2017, closing a stake of 6 shares — an estimated $5K sold.

Guggenheim Capital first reported a position in IMNN in Q2 2013 and held it in 4 quarters. The position peaked at $23K in Q3 2013. 17 funds tracked by Wall St. Rank hold IMNN as of Q1 2017.

  • Guggenheim Capital reported no remaining Imunon position as of Q1 2017 after selling out during the quarter.
  • Guggenheim Capital sold 6 Imunon shares in Q1 2017, an estimated $5K.
  • Guggenheim Capital first reported a position in Imunon in Q2 2013 and held it in 4 quarters.
  • Guggenheim Capital's Imunon position peaked at $23K in Q3 2013.
  • 17 funds tracked by Wall St. Rank held Imunon as of Q1 2017.

Based on Guggenheim Capital's 13F filing for Q1 2017, filed 15 May 2017.